Back

Apabetalone (RVX-208) inhibits key drivers of vascular inflammation, calcification, and plaque vulnerability through a BET-dependent epigenetic mechanism

3 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 6 - Coronary artery disease inflammation Inflammation and Immunity ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Ewelina Kulikowski

Calgary (Canada)

10 More presentations in this session

Presentation thumbnail
Doctor M. Karim (Oxford, GB)
Abstract Slides
Presentation thumbnail
Professor P. Pignatelli Spinazzola (Rome, IT)
Abstract Slides
Presentation thumbnail
Doctor D. Takagi (Kyouto, JP)
Abstract
Presentation thumbnail
Doctor H. Yamamoto (Kobe, JP)
Abstract Slides
Presentation thumbnail
Mrs H. Grauen Larsen (Malmo, SE)
Abstract

Access the full session

Session thumbnail
Poster Session 6 - Coronary artery disease inflammation

The Event

Event poster

ESC Congress 2019

3 September 2019 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources